Literature DB >> 10670475

Bystander activation of CD4+ T cells accounts for herpetic ocular lesions.

S Gangappa1, S P Deshpande, B T Rouse.   

Abstract

PURPOSE: Stromal keratitis is an immunopathologic consequence of herpes simplex virus (HSV) infection of the cornea. The lesion is immunopathologic, but the identities of molecules that drive the reaction remain unresolved. To exclude viral antigen recognition as a necessary step in the disease process, ocular HSV infection was followed in Tg-RAG mice (OVA-TCR transgenic mice crossed to RAG2-deficient mice) whose limited T-cell repertoire did not include immune responsiveness to HSV.
METHODS: Mice with T-cell specificity to OVA peptide (Tg-RAG mice) as well as control DO11.10 and BALB/c mice were infected with HSV on the scarified cornea and subjected to clinical, histologic, and immunologic analysis. To evaluate involvement of OVA-specific CD4+ T cells in lesion development in Tg-RAG mice, monoclonal antibody to CD4+ T cells was used for in vivo CD4+ T-cell depletion.
RESULTS: Tg-RAG mice were capable of eliciting ocular lesions in the absence of detectable reactivity to viral antigens. Lesion manifestation in Tg-RAG mice was CD4+ T-cell dependent and the cellular infiltrates and their inflammatory products in the HSV-infected cornea were comparable to similarly infected BALB/c and DO11.10 mice.
CONCLUSIONS: The authors conclude that mechanisms other than viral antigen recognition, and hence molecular mimicry, are at play and are sufficient to cause HSV-induced stromal keratitis. The data imply a significant role for non-virus-specific CD4+ T cells that could become activated by an inflammatory milieu consisting of enhanced accessory molecules and proinflammatory cytokines in the cornea.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10670475

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  20 in total

Review 1.  Herpesvirus Entry Mediator and Ocular Herpesvirus Infection: More than Meets the Eye.

Authors:  Rebecca G Edwards; Richard Longnecker
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis.

Authors:  S P Deshpande; S Lee; M Zheng; B Song; D Knipe; J A Kapp; B T Rouse
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 3.  Corneal ulceration in pediatric patients: a brief overview of progress in topical treatment.

Authors:  Serina Stretton; Usha Gopinathan; Mark D P Willcox
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

4.  Efficient generation and rapid isolation via stoplight recombination of Herpes simplex viruses expressing model antigenic and immunological epitopes.

Authors:  Rebecca L Sanchez; Alistair J Ramsay; Timothy P Foster
Journal:  J Virol Methods       Date:  2011-10-20       Impact factor: 2.014

Review 5.  Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates?

Authors:  Gargi Dasgupta; Lbachir BenMohamed
Journal:  Vaccine       Date:  2011-06-28       Impact factor: 3.641

Review 6.  Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization.

Authors:  Fernanda Giménez; Amol Suryawanshi; Barry T Rouse
Journal:  Prog Retin Eye Res       Date:  2012-08-07       Impact factor: 21.198

Review 7.  Corneal lymphangiogenesis in herpetic stromal keratitis.

Authors:  Paul J Park; Michael Chang; Nitin Garg; Jimmy Zhu; Jin-Hong Chang; Deepak Shukla
Journal:  Surv Ophthalmol       Date:  2014-06-10       Impact factor: 6.048

8.  CD154 signaling regulates the Th1 response to herpes simplex virus-1 and inflammation in infected corneas.

Authors:  Min Xu; Andrew J Lepisto; Robert L Hendricks
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

9.  Non-mitogenic anti-CD3F(ab')2 monoclonal antibody: a novel approach to control herpetic stromal keratitis.

Authors:  Pranita P Sarangi; Bumseok Kim; Barry T Rouse
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-08       Impact factor: 4.799

10.  In vitro-generated antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells control the severity of herpes simplex virus-induced ocular immunoinflammatory lesions.

Authors:  Sharvan Sehrawat; Susmit Suvas; Pranita P Sarangi; Amol Suryawanshi; Barry T Rouse
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.